…particularly relevant for GLP-1 receptor agonists. For example, semaglutide has demonstrated dose-dependent effects on glycemic control and…
glucagon-like peptide-1 receptor agonists
This drug is selected. Its supporting articles are shown below.
Articles mentioning glucagon-like peptide-1 receptor agonists
32 articles · page 1 of 3… among the GLP-1RA group compared with the sulfonylureas group. GLP-1RA=glucagon-like peptide-1 receptor agonistsDiscussionIn this nati…
…therapy with SGLT2i and GLP-1 RA relative to those who received SGLT2i monotherapy was significantly lower in patients with HF and T2D…
…aluate the effect of Glucagon-like peptide-1 receptor agonists (GLP-1RAs) use on the incidence of ICH and mortality in patients with unr…
…Objective Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are increasingly recognised for benefits beyond glycaemic cont…
…ts. A narrative review of non-hormonal therapies was conducted. Metformin is associated with modest reductions in body weight and improve…
…vidence in hip OA is sparse with weaker associations.Conclusion GLP-1-RAs represent a promising adjunct for managing individuals with OA …
…19) remained off exogenous insulin without need for concomitant GLP-1RA, and 84.2% (n=16) maintained a HbA1c ≤7.5%. Oral GLAs were incr…
…Background Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) delay gastric emptying and may increase aspiration risk, but t…
…e clinical outcomes. Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are effective metabolic therapies with potential anti-inflamma…
…duals at borderline or intermediate risk of ASCVD.16 Similarly, FIB-4 may serve an analogous role in nephrology by identifying patien…